What type of study is this?

Injectable Ferric Carboxy Maltose Versus Oral Ferrous Fumerrate in Treatment of Iron Deficiency Anaemia in Pregnancy- A Randomized Controlled Trial

View Full Paper

Ask AI

Bookmark

Authors

Randomized controlled trial shows ferric carboxymaltose improves hemoglobin in pregnant women, suggesting better outcomes over oral iron.

Ferric carboxymaltose resulted in a significantly higher hemoglobin increase than oral iron, improving treatment outcomes significantly.
After 6 weeks, 65.4% of women treated with ferric carboxymaltose achieved hemoglobin levels ≥ 11 gm%, versus 44.9% with oral iron.
This randomized controlled trial involved 156 pregnant women and compared the efficacy and safety of two different iron supplementation methods.
Ferric carboxymaltose had lower gastrointestinal adverse events compared to oral iron, emphasizing its safety profile.

Jabeen et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark